@pemile
Je regarde votre premier lien, aucun rapport avec l’HCQ ??!!
Table 4
shows the management given to hospitalized patients. Almost all
patients were given LMWH and antibiotics, with all males receiving the
latter (p=0.02). Majority (∼97%) also received vitamin C, vitamin D and
azithromycin. Majority also received hydroxychloroquine (89%) and
dexamethasone (68.7%).
Table 5 ...
... Among the treatment options, patients who were given
methylpredinosolone, dexamethasone, hydroxychloroquine and azithromycin
were significantly less likely to die from Covid-19 by as much as 65%,
80%, 88% and 97%, respectively.
3. Discussion
....
Worthy to mention are the protective effects of corticosteroids
(dexamethasone and methylprednisolone) as well as hydroxychloroquine
from severe Covid-19 outcomes. Hydroxychloroquine in particular protects
from Covid-19 death by 88% in the dataset studied. This percentage,
while much higher compared to other recent studies done elsewhere [16], [17], [18],
reiterates that the use of hydroxychloroquine is associated with
reduced Covid-19 mortality. Several studies however do not consider the
use of hydroxychloroquine beneficial for Covid-19 treatment [19], [20].
These differences can be partly explained by differences in research
methods, some of which were flawed and biased given the premature media
attention it received prior to approval [21]. The use of hydroxychloroquine however in Saudi Arabia is approved by the Ministry of Health.
....
Donc si il y en a un qui se fout de la gueule de l’autre c’est bien vous.
Vous êtes pénible ...
Avant d’écrire apprenez à lire sinon je vais croire que vous testez la dernière molécule megatroll de Big Pharma ...